- Home
- TXMD vs GCO Comparison
TXMD vs GCO Comparison
Compare TXMD & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TXMD | GCO |
|---|---|---|
| Founded | 2008 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9M | 284.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TXMD | GCO |
|---|---|---|
| Price | $2.35 | $27.81 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $31.33 |
| AVG Volume (30 Days) | 102.0K | ★ 216.4K |
| Earning Date | 03-26-2026 | 03-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.03 | 0.00 |
| Revenue | $2,796,000.00 | ★ $2,382,104,000.00 |
| Revenue This Year | $427.09 | $5.42 |
| Revenue Next Year | N/A | $2.41 |
| P/E Ratio | ★ $92.75 | $7,527.11 |
| Revenue Growth | ★ 75.19 | 2.76 |
| 52 Week Low | $0.72 | $16.19 |
| 52 Week High | $2.95 | $41.52 |
Technical Indicators
Market Signals| Indicator | TXMD | GCO |
|---|---|---|
| Relative Strength Index (RSI) | 56.98 | 41.74 |
| Support Level | $2.12 | $27.38 |
| Resistance Level | $2.45 | $29.49 |
| Average True Range (ATR) | 0.23 | 1.50 |
| MACD | -0.01 | -0.48 |
| Stochastic Oscillator | 39.08 | 13.34 |
Price Performance
Historical ComparisonAbout TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About GCO Genesco Inc.
Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.